Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
sickle cell disease
Pharma
Vertex gains FDA expansion of Casgevy to those ages 2 and older
The FDA has granted a label expansion for children ages 2 and up to receive Vertex's gene therapy Casgevy for sickle cell disease or beta thalassemia.
Kevin Dunleavy
Jul 6, 2026 11:30am
Agios’ Pyrukynd turns in mixed results in sickle cell ph. 3
Nov 19, 2025 12:00pm
Pfizer debuts video series about life with sickle cell disease
Jun 9, 2025 1:25pm
Amid ongoing launches, Novo eyes rare disease leadership
Mar 7, 2025 9:20am
Pfizer pulls sickle cell disease drug Oxbryta from global markets
Sep 25, 2024 6:00pm
New York hospital creates basketball for sickle cell push
Sep 10, 2024 11:51am
